Monetizing Obesity Medicine

GLP-1 medications have transformed the treatment of obesity, offering unprecedented improvements in weight loss and overall health. Yet despite their remarkable effectiveness, most patients abandon treatment within months, regaining weight and losing many of the health benefits they worked so hard to achieve. Monetizing Obesity Medicine explores the critical question that healthcare leaders, physicians, investors, and entrepreneurs have largely overlooked: if the science works, why is the system failing? Drawing on frontline clinical experience and years spent designing large-scale obesity programs, White reveals the hidden structural barriers preventing millions of people from achieving lasting success with treatment. Part healthcare manifesto, part business strategy, and part practical blueprint, this book challenges conventional thinking about obesity care and the role of markets in medicine. Through compelling patient stories, sharp analysis of the obesity treatment landscape, and lessons drawn from some of the world's most successful consumer businesses, readers are introduced to a new model for delivering sustainable, scalable obesity care. Whether you are a healthcare professional, policymaker, entrepreneur, investor, or patient advocate, this unique guide offers a provocative and actionable vision for solving one of the most important public health challenges of our time.